Skip to main content
SpringerLink
Log in

Effects of calcium antagonists on the hypertensive kidney

  • Focused Subsection: Calcium Antagonists and the Kidney
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

This review focuses on the effects of calcium antagonists on renal function in hypertensive human subjects. Specifically assessed are the acute and chronic effects of diltiazem, verapamil, amlodipine, felodipine, isradipine, nicardipine, nifedipine, and nitrendipine on glomerular filtration rate; effective renal plasma flow/renal blood flow; renal vascular resistance; and urinary protein excretion. Among the calcium antagonists, only the dihydropyridine derivatives have been demonstrated consistently to acutely increase effective renal plasma flow/renal blood flow. The acute effects on glomerular filtration rate are variable. With respect to chronic therapy, many of the calcium antagonists have been reported to produce sustained increases in the effective renal plasma flow/renal blood flow and/or the glomerular filtration rate. Renal vascular resistance is reduced. Although calcium antagonists preserve or improve renal perfusion and glomerular filtration, long-term clinical trials are required to determine their potential therapeutic benefit to modify the natural course of hypertensive renal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Reams GP, Lau A, Messina C, et al. Efficacy, electrocardiographic and renal effects of intravenous diltiazem for essential hypertension.Am J Cardiol 1987;60:781–841.

    Google Scholar 

  2. Blackshear JL, Garnic D, Williams GH, et al. Exaggerated renal vasodilator response to calcium entry blockade in first-degree relatives of essential hypertensive subjects.Hypertension 1987;9:384–389.

    PubMed  Google Scholar 

  3. Sakurai T, Kurita T, Nagamo S, Sonoda T. Antihypertensive, vasodilating and sodium diuretic actions of D-cisisomer of benzothiazepine derivative (CRD-401).Acta Urologica Japonica 1972;18:695–707.

    Google Scholar 

  4. Tojo S, Shishido H, Yamamoto S. Effects of CRD-401 on blood pressure and renal function.Jpn J Clin Exp Med 1972;49:1958–1966.

    Google Scholar 

  5. Sunderrajan S, Reams GP, Bauer JH. Renal effects of diltiazem in primary hypertension.Hypertension 1986;8:238–242.

    PubMed  Google Scholar 

  6. Sunderrajan S, Reams G, Bauer JH. Long-term renal effects of diltiazem in essential hypertension.Am Heart J 1987;114:383–388.

    PubMed  Google Scholar 

  7. Leonetti G, Cuspidi C, Sampieri L, et al. Comparison of cardiovascular, renal and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.J Cardiovasc Pharmacol 1982;4:S319-S324.

    PubMed  Google Scholar 

  8. Leonetti G, Sala C, Bianchini C, et al. Antihypertensive and renal effects of orally administered verapamil.Eur J Clin Pharmacol 1980;18:375–382.

    Google Scholar 

  9. deLeeuw PW, Birkenhager WH. Effects of verapamil in hypertensive patients.Acta Med Scand 1984;681(Suppl):125–128.

    Google Scholar 

  10. Sorenson SS, Thomsen O, Danielsen H, Pedersen EB. Effect of verapamil on renal plasma flow, glomerular filtration rate and plasma angiotensin II, aldosterone and arginine vasopressin in essential hypertension.Eur J Clin Pharmacol 1985;29:257–261.

    PubMed  Google Scholar 

  11. Kubo SH, Cody RJ, Covit AB, et al. The effects of verapamil on renal blood flow, renal function, and neurohormonal profiles in patients with moderate to severe hypertension.J Clin Hypertens 1986;3:38S-46S.

    Google Scholar 

  12. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Cardiovascular effects of verapamil in patients with essential hypertension.Circulation 1987;75:1030–1036.

    PubMed  Google Scholar 

  13. Reams GP, Lau A, Hamory A, Bauer JH. Amlodipine therapy corrects renal abnormalities encountered in the hypertensive state.Am J Kidney Dis 1987;10:446–451.

    PubMed  Google Scholar 

  14. Hulthen UL, Katzman PL. Renal effects of acute and long-term treatment with felodipine in essential hypertension.J Hypertens 1988;6:231–237.

    PubMed  Google Scholar 

  15. Leonetti G, Gradnik R, Terzoli L, et al. Felodipine, a new vasodilating drug: Blood pressure, cardiac, renal, and humoral effects in hypertensive patients.J Cardiovasc Pharmacol 1984;6:392–398.

    PubMed  Google Scholar 

  16. Krusell LR, Jespersen LT, Schmitz A, et al. Repetitive natriuresis and blood pressure.Hypertension 1987;10:577–581.

    PubMed  Google Scholar 

  17. Van Schaik BAM, Van Nistelrooy AEJ, Geyskes GG. Antihypertensive and renal effects of nicardipine.Br J Clin Pharmacol 1984;18:57–63.

    PubMed  Google Scholar 

  18. Chaignon M, Bellet M, Lucsko M, et al. Acute and chronic effects of a new calcium inhibitor, nicardipine, on renal hymodynamics in hypertension.J Cardiovasc Pharmacol 1986;8:892–897.

    PubMed  Google Scholar 

  19. Baba T, Boku A, Ishizaki T, et al. Renal effects of nicardipine in patients with mild-to-moderate essential hypertension.Am Heart J 1986;111:552–557.

    PubMed  Google Scholar 

  20. Smith SA, Rafiqi EI, Gardener EG, et al. Renal effects of nicardipine in essential hypertension: Differences between acute and chronic therapy.J Hypertens 1987;5:693–697.

    PubMed  Google Scholar 

  21. Klutech VK, Schmidt P, Grosswendt J. Der einfluss von Bay a 1040 auf die nierenfunktion des hypertonikers.Arzneim-Forsch 1972;22:377–380.

    Google Scholar 

  22. Yokoyama S, Kuburagi T. Clinical effects of intravenous nifedipine on renal function.J Cardiovasc Pharmacol 1983;5:67–71.

    PubMed  Google Scholar 

  23. Tsunoda K, Ake K, Omata K, et al. Hypotensive and natriuretic effects of nifedipine in essential hypertension.J Clin Hypertens 1986;3:263–270.

    Google Scholar 

  24. Bruun NE, Ibsen H, Nielsen F, et al. Lack of effect of nifedipine in counterregulatory mechanisms in essential hypertension.Hypertension 1986;8:655–661.

    PubMed  Google Scholar 

  25. Reams GP, Hamory A, Lau A, Bauer JH. Effect of nifedipine on renal function in patients with essential hypertension.Hypertension 1988;11:452–456.

    PubMed  Google Scholar 

  26. Thananopavarn C, Golub MS, Eggena P, et al. Renal effects of nitrendipine monotherapy in essential hypertension.J Cardiovasc Pharmacol 1984;6:S1032-S1036.

    PubMed  Google Scholar 

  27. Lupinacci L, Palomino C, Greenberg A, Puschett JB. Chronic effects of nitrendipine on renal hemodynamics and tubular transport.Clin Pharmacol Ther 1988;43:6–15.

    PubMed  Google Scholar 

  28. Simon G, Snyder DK. Altered pressor responses in longterm nitrendipine treatment.Clin Pharmacol Ther 1984;36:315–319.

    PubMed  Google Scholar 

  29. Luft FC, Aronoff GR, Sloan RS, et al. Calcium channel blockade with nitrendipine.Hypertension 1985;7:438–442.

    PubMed  Google Scholar 

  30. Pedrinelli R, Fouad FM, Tarazi RC, et al. Nitrendipine, a calcium-entry blocker.Arch Intern Med 1986;146:62–65.

    PubMed  Google Scholar 

  31. Bauer JH, Reams GP. Short- and long-term effects of calcium entry blockers on the kidney.Am J Cardiol 1987;59:66A-71A.

    PubMed  Google Scholar 

  32. Romero JC, Raij L, Granger JP, et al. Multiple effects of calcium entry blockers on renal function in hypertension.Hypertension 1987;10:140–151.

    PubMed  Google Scholar 

  33. Anderson S, Clarey LE, Riley SL, Troy JL. Acute infusion of calcium channel blockers (CCB) reduces glomerular capillary pressure (PGC) in rats with reduced renal mass (abstract).Kidney Int 1988;22:370A.

    Google Scholar 

  34. Diamond JR, Cheung JY, Fang LS. Nifedipine induced renal dysfunction.Am J Med 1984;77:905–909.

    PubMed  Google Scholar 

  35. TerWee PM, Rosman JB, Van der Geest S. Acute renal failure due to diltiazem.Lancet 1984;2:1337–133.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Nephrology, Hypertension Section, University of Missouri School of Medicine, Columbia, MO, USA

    Garry P. Reams MD & John H. Bauer

Authors
  1. Garry P. Reams MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John H. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reams, G.P., Bauer, J.H. Effects of calcium antagonists on the hypertensive kidney. Cardiovasc Drug Ther 4, 1331–1335 (1990). https://doi.org/10.1007/BF02018260

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02018260

Key Words

Search

Navigation